Advertisement

Effects of Cannabis on Fetal Development of Rodents

  • Harris Rosenkrantz

Abstract

The majority of teratologic studies on marihuana and Δ9-THC in rodents have been negative but serious observations of cleft palate in mice and eventrations in rabbits remain unexplained. There has been agreement on the increased incidence of in utero deaths. To clarify the potential effects of cannabinoids on fetal development, studies were performed in rodents using the inhalation and oral routes. The Δ9-THC doses in marihuana smoke were 0.8–3.8 mg/kg, which correlated with plasma Δ 9 -THC levels of 73–297 ng/mL and carboxyhemoglobin levels between 21 and 60%. Oral Δ9-THC doses were 5–600 mg/kg for mice and 12–50 mg/kg for rats. An automatic inhalator provided a 50-mL puff from each of three NIDA cigarettes in a two-second puff, retention of smoke for a 30-second exposure interval followed by a 30-second fresh air purge each min. Exposure to smoke was performed during days 6–15 of gestation. Oral studies included a similar treatment protocol but in addition the number of treatments and days of treatment were varied to establish the time of greatest effect on fetal development. The embryocidal effect of marihuana and Δ9-THC was demonstrated by two routes and in two rodent species. In fact, whole litter resorption was encountered and two to five treatments around days 7 to 9 of gestation were sufficient to induce embryotoxicity. At least in mice, the fetocidal effect appeared to be related to vaginal bleeding, possibly a consequence of interrupted development of fetoplacental circulation and deranged hormone balance. No drug-related teratogenic effects were found.

Keywords

Vaginal Bleeding Cleft Palate Uterine Weight Inhalation Study Oral Study 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Agnew, W. F., Rumbaugh, C. L., and Cheng, J. T. (1976), The uptake of A9-tetrahydrocannabinol in choroid plexus and brain cortex in vitro and in vivo. Brain Res. 109, 335–366.CrossRefGoogle Scholar
  2. 2.
    Agurell, S., Gustafsson, B., and Holstedt, B. (1973), Quantitation of Al-tetrahydrocannabinol in plasma from cannabis smokers. J. Pharm. Pharmacol. 25, 554–558.PubMedCrossRefGoogle Scholar
  3. 3.
    Astrup, P., Olsen, H. M., Trolle, D., and Kjeldsen, K., (1972) Effect of moderate carbon-monoxide exposure on fetal development. Lancet, 1 1220–1222.CrossRefGoogle Scholar
  4. 4.
    Banerjee, B. M., Galbreath, C., and Sofia, R. D. (1975), Teratologic evaluation of synthetic A9-tetrahydrocannabinol in rats. Teratology 11, 99–102.PubMedCrossRefGoogle Scholar
  5. 5.
    Becker, B. A., (1975) in Toxicology, (Casarett, L. J. and Doull, J. eds.) Macmillan, New York, pp. 313–332.Google Scholar
  6. 6.
    Biddle, F. G. (1977) 6-Aminonicotinamide-induced cleft palate in the mouse: the nature of the difference between the A/J and C57BL/6J strains in frequency of response and its genetic basis. Teratology 16, 301–312.Google Scholar
  7. 7.
    Binns, R., Beven, J. L., Wilton, L. V., and Lugton, W. G. D. (1976) Inhalation toxicity studies on cigarette smoke. 11. Tobacco smoke inhalation dosimetry studies on small laboratory animals. Toxicology 6, 197–206.PubMedCrossRefGoogle Scholar
  8. 8.
    Borgen, L. A., Davis, W. M., and Pace, H. B. (1971) Effects of synthetic A9-tetrahydrocannabinol on pregnancy and offspring in the rat. Toxicol. Appl. Pharmacol. 20, 480–486.PubMedCrossRefGoogle Scholar
  9. 9.
    Borgen, L. A., Davis, W. M., and Pace, H. B. (1973) Effects of prenatal A9-tetrahydrocannabinol on the development of rat offspring. Pharmacol. Biochem. Behay. 1, 203–206.CrossRefGoogle Scholar
  10. 10.
    Braude, M. C. and Szara, S. (1976) Pharmacology of Marihuana, vol. 2, Raven Press, New York, 461–492.Google Scholar
  11. 11.
    Bromley, B. and Zimmerman, E. (1976) Divergent release of prolactin and corticosterone following A9tetrahydrocannabinol injection in male rats. Fed. Proc. 35, 220.Google Scholar
  12. 12.
    Chakravarty, I. and Ghosh, J. J. (1977) Effect of cannabis extract on uterine glycogen metabolism in prepubertal rats under normal and estradiol-treated conditions. Biochem. Pharmacol. 26, 859–863.PubMedCrossRefGoogle Scholar
  13. 13.
    Chakravarty, I., Sheth, A. R., and Ghosh, J. J. (1975) Effect of acute A9-tetrahydrocannabinol treatment on serum luteinizing hormone and prolactin levels in adult female rats. Fertil. Steril. 26, 947–948.PubMedGoogle Scholar
  14. 14.
    Chao, F.-C., Green, D. E., Forrest, I. S., Kaplan, J. N., Winship-Ball, A., and Braude, M. C. (1976) The passage of 14C-A9-tetrahydrocannabinol into the milk of lactating squirrel monkeys. Res. Comm. Chem. Pathol. Pharmacol. 15, 303–317.Google Scholar
  15. 15.
    Collu, R., Letarte, J., Leboeuf, G., and Ducharme, J. R. (1975) Endocrine effects of chronic administration of psychoactive drugs to prepubertal male rats. I. A9-Tetrahydrocannabinol. Life Sci. 16, 533–542.PubMedGoogle Scholar
  16. 16.
    Dixit, V. P., Arya, M., and Lohiya, N. K. (1975) The effect of chronically administered cannabis extract on the female genital tract of mice and rats. Endokrinologie 66, 365–368.PubMedGoogle Scholar
  17. 17.
    Dubowski, K. M. (1964) Measurement of hemoglobin derivatives, in ( Sunderman, F. W. and Sunderman, F. W., Jr, eds.), Haemoglobin: Its Precursors and Metabolites, Lippincott, Philadelphia, pp. 49–60.Google Scholar
  18. 18.
    Erdmann, G., Just, W. W., Thel, S., Werner, G., and Wiechmann, M., (1976) Comparative autoradiographic and metabolic study of A8 and A9-tetrahydrocannabinol in the brain of the marmoset callithrix jacchus. Psychopharmacol. 47, 53–58.CrossRefGoogle Scholar
  19. 19.
    Esber, H. J., Rosenkrantz, H., Kuo, E. H., and Braude, M. C. (1975) Serum hormone levels in non-pregnant rats after chronic oral treatment with A9-tetrahydrocannabinol. Fed. Proc. 34, 783.Google Scholar
  20. 20.
    Fechter, L. D. (1978) Persistent neurotoxic effects of mild prenatal carbon monoxide exposure. 17th Ann. Meet. Soc. Toxicol.105. Google Scholar
  21. 21.
    Fechter, L. D. and Annau, Z. (1977) Toxicity of mild prenatal carbon monoxide exposure. Science 197, 680–682.PubMedCrossRefGoogle Scholar
  22. 22.
    Fleischman, R. W., Hayden, D. W., Naqvi, R. H., Rosenkrantz, H., and Braude, M. C., The embryotoxic effects of cannabinoids in rats and mice. J. Environ. Pathol. Toxicol. (being reviewed).Google Scholar
  23. 23.
    Fleischman, R. W., Hayden, D. W., Rosenkrantz, H., and Braude, M. C. (1975) Prenatal effects of A9-tetrahydrocannabinol in mice including a review of the literature. Teratology 12, 47–50.PubMedCrossRefGoogle Scholar
  24. 24.
    Fournier, E., Rosenberg, M., Hardy, N., and Nahas, G. G. (1976) Teratologic effects of cannabis extracts in rabbits, in Marihuana: Chemistry, Biochemistry and Cellular Effects, ( Nahas, G. G., ed.) Springer-Verlag, New York, pp. 457–468.Google Scholar
  25. 25.
    Freudenthal, R. I., Martin, J., and Wall, M. E. (1972) Distribution of A9-tetrahydrocannabinol in the mouse. Brit. J. Pharmacol. 44, 244–249.Google Scholar
  26. 26.
    Fried, P. A. (1976) Short and long-term effects of prenatal cannabis inhalation upon rat offspring. Psychopharmacology 50, 285–291.PubMedCrossRefGoogle Scholar
  27. 27.
    Fried, P. A. and Nieman, G. W. (1973) Inhalation of cannabis smoke in rats. Pharmacol. Biochem. Behay. 1, 371–378.CrossRefGoogle Scholar
  28. 28.
    Galanter, M., Wyatt, R. J., Lemberger, L., Weingartner, H., Vaughan, T. B., and Roth, W. T. (1972) Effects on humans of delta-9-tetrahydrocannabinol administered by smoking. Science 176, 934–936.PubMedCrossRefGoogle Scholar
  29. 29.
    Geber, W. F. and Schramm, L. C. (1969) Effect of marihuana extract on fetal hamsters and rabbits. Toxicol. Appl. Pharmacol. 14, 276–282.PubMedCrossRefGoogle Scholar
  30. 30.
    Gill, E. W. and Lawrence, D. K. (1974) Blood and brain levels of Al-tetrahydrocannabinol in mice. The effect of 7-hydroxy-A1-tetrahydrocannabinol. Biochem. Pharmacol. 23, 1140–1143.PubMedCrossRefGoogle Scholar
  31. 31.
    Ginsberg, M. D. and Myers, R. E. (1976) Fetal brain injury after maternal carbon monoxide intoxication. Neurology 26, 15–23.PubMedCrossRefGoogle Scholar
  32. 32.
    Grabowski, C. T. (1976) Postnatal effects on rats of prenatal exposure to carbon monoxide. Teratology 13, 23a.Google Scholar
  33. 33.
    Gross, S. J., Soares, J. R., Wong, S. L. R., and Schuster, R. E. (1974) Marijuana metabolites measured by a radioimmune technique. Nature 252, 581–582.PubMedCrossRefGoogle Scholar
  34. 34.
    Haley, S. L., Wright, P. L., Plank, J. B., Keplinger, M. L., Braude, M. C., and Calendra, J. C. (1973) The effect of natural and synthetic A9-tetrahydrocannabinol on fetal development. Toxicol. Appl. Pharmacol. 25, 450.Google Scholar
  35. 35.
    Harbison, R. D. and Manttlla-Plata, B. (1972) Prenatal toxicity, maternal distribution and placental transfer of tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 180, 446–453.PubMedGoogle Scholar
  36. 36.
    Harbison, R. D., Mantilla-Plata, B., and Lubin, D. J. (1977) Alternation of A9-tetrahydrocannabinol-induced teratogenicity of stimulation and inhibition of its metabolism. J. Pharmacol. Exp. Ther. 202, 455–465.PubMedGoogle Scholar
  37. 37.
    Hattori, T. and Mcgeer, P. L. (1977) Electron microscopic autoradiography and A8-(3H)-tetrahydrocannabinol localization in brain tissue. Toxicol. Appl. Pharmacol. 39, 307–311.PubMedCrossRefGoogle Scholar
  38. 38.
    Hilado, C. J. and Cumming, H. J. (1977) Effect of carbon monoxide on Swiss albino mice. J. Combust. Toxicol. 4, 216–230.Google Scholar
  39. 39.
    Idanpaan-Heikkila, J. E., Fritchie, G. E., Englert, L. F., Ho, B. T. and McIsaac, W. M. (1969) Placental transfer of tritiated-1–6,9-tetrahydrocannabinol. N. Engl. J. Med. 281, 330–332.PubMedGoogle Scholar
  40. 40.
    Jakubovic, A., Hattori, T., and Mcgeer, R L. (1973) Radioactivity in suckled rats after giving carbon-14-labeled tetrahydrocannabinol to the mother. Eur. J. Pharmacol. 22, 221–223.PubMedCrossRefGoogle Scholar
  41. 41.
    Jakubovic, A., McGeer, R. L., and Fitzsimmons, R. C. (1976) Effects of 6,9-tetrahydrocannabinol and ethanol on body weight protein and nucleic acid synthesis in chick embryos. J. Toxicol. Environ. Health 1, 441–447.PubMedCrossRefGoogle Scholar
  42. 42.
    Jonfja, M. G. (1976) A study of teratologic effects of intravenous, subcutaneous and intragastric administration of A9-tetrahydrocannabinol in mice. Toxicol. Appl. Pharmacol. 36, 151–162.CrossRefGoogle Scholar
  43. 43.
    Joneja, M. G. (1977) Effects of A9-tetrahydrocannabinol on hamster fetuses. J. Toxicol. Environ. Health 2, 1031–1040.PubMedCrossRefGoogle Scholar
  44. 44.
    Kennedy, J. S. and Waddell, W. J. (1972) Whole-body autoradiography of the pregnant mouse after administration of 14C-A9-THC. Toxicol. Appl. Pharmacol. 22, 252–258.PubMedCrossRefGoogle Scholar
  45. 45.
    Keplinger, M. L., Wright, R. L., Haley, S. L., Plank, J. B., Braude, M, C. and Calandra, J. C. (1973) The effect of natural and synthetic delta-9-tetrahydrocannabinol on reproductive and lactation performance in albino rats. Toxicol. Appl. Pharmacol. 25, 449.Google Scholar
  46. 46.
    Kokka, N. and Garcia, J. F. (1974) Effects of A9-THC (tetrahydrocannabinol) on growth hormone and ACTH secretion in rats. Life Sci. 15, 329–338.PubMedCrossRefGoogle Scholar
  47. 47.
    Kramer, J. and Ben-David, M. (1974) Suppression of prolactin secretion by acute administration of A9-THC in rats. Proc. Soc. Exp. Biol. Med. 17, 482–484.Google Scholar
  48. 48.
    Layman, J. M. and Milton, A. S. (1971) Distribution of tritium labelled Al-tetrahydrocannabinol in the rat brain following intraperitoneal administration. Br. J. Pharmacol. 42, 308–310.PubMedCrossRefGoogle Scholar
  49. 49.
    Leighty, E. G. (1973) Metabolism and distribution of cannabinoids in rats after different methods of administration. Biochem. Pharmacol. 22, 1613–1621.PubMedCrossRefGoogle Scholar
  50. 50.
    Lemberger, L. (1973) Tetrahydrocannabinol metabolism in man. Drug Metab. Dispos. 1, 461–468.PubMedGoogle Scholar
  51. 51.
    Maker, B. S., Khan, M. A., and Lehrer, G. M. (1974) The effect of self regulated A9-tetrahydrocannabinol consumption of pregnant mice and offspring. Fed. Proc. 33, 540.Google Scholar
  52. 52.
    Mantilla-Plata, B., Clewe, G. L., and Harbison, R. D. (1975) A9-Tetrahydrocannabinol-induced changes in prenatal growth and development of mice. Toxicol. Appl. Pharmacol. 33, 333–340.PubMedCrossRefGoogle Scholar
  53. 53.
    Mantilla-Plata and Harbison, R. D. (1976) Influence of alteration of tetrahydrocannabinol metabolism on tetrahydrocannabinol-induced teratogenesis, in Pharmacology of Marihuana, vol. 2, ( Braude, M. C. and Szara, S. eds.) Raven, New York, pp. 733–746.Google Scholar
  54. 54.
    Marihuana and Health (1977) Sixth Annual Report to Congress, Department of Health, Education and Welfare, Publ. No. (ADM) 77–443.Google Scholar
  55. 55.
    Martin, B. R., Dewey, W. L., Han-is, L. S., and Bechner, J. S. (1976) 3H-A9-tetrahydrocannabinol distribution in pregnant dogs and their fetuses. Res. Comm. Chem. Pathol. Pharmacol. 17, 457–470.Google Scholar
  56. 56.
    Martin, B. R., Harvey, D. J., and Paton, W. D. M. (1977) Biotransformation of cannabidiol in mice: identification of new acid metabolites. Drug. Metab. Disp. 5, 259–267.Google Scholar
  57. 57.
    Maskarinec, M. P., Shipley, G., Novotny, M., Brown, D. J., and Forney, R. B. (1978) Different effects of synthetic delta-9-tetrahydrocannabinol and cannabis extract on steroid metabolism in male rats. Experientia 34, 88–89.PubMedCrossRefGoogle Scholar
  58. 58.
    Mcisaac, W. M., Fritchie, G. E., Idanpaan-Heikkila, J. E., Ho, B. T., and Englert, L. F. (1971) Distribution of marihuana in monkey brain and concomitant behavioral effects. Nature 230, 593–594.PubMedCrossRefGoogle Scholar
  59. 59.
    Miras, C. J. (1965) Some aspects of cannabis action. in Hashish: Its Chemistry and Pharmacology ( Wolstenholme, G. E. W. and Knight, J. eds.) Little, Brown, Boston, MA, pp. 37–52.Google Scholar
  60. 60.
    Nahas, G. G., Paton, W. D. M., and Idanpaan-Heikkila, J. E. (1976) Marihuana, Chemistry, Biochemistry and Cellular Effects. Springer-Verlag, New York, pp. 3–556.Google Scholar
  61. 61.
    Nettesheim, P., Guerin, M. R., Kendrick, J., Rubin, I., Stokely, J., Creasia, D., Maddox, W., and Caton, J. E. (1975) Control and maximization of tobacco smoke dose in chronic animal studies, in Proceedings of the Tobacco Smoke Inhalation Workshop on Experimental Methods in Smoking and Health Research. DHEW Publ. No. (NIH) 75–906. ( Gori, G. B., ed. ) pp. 17–26.Google Scholar
  62. 62.
    Nikitovitch-Winer, M. B., and Ferry, J. D. (1973) Influence of smoking on reproductive process in the rat. Proc. Un. Kent. Tobacco & Health Res. Inst. Rep. 4, 337–359.Google Scholar
  63. 63.
    Nir, I., Ayalon, D., Tsafrirl A., Cordova, T., and Lindner, H. R. (1973) Al-Tetrahydrocannabinol: suppression of the cyclic surge of LH secretion and of ovulation in the rat. Nature 243, 470.PubMedCrossRefGoogle Scholar
  64. 64.
    Okey, A. B. and Bondy, G. P. (1978) A9-Tetrahydrocannabinol and 17-ß-estradiol bind to different macromolecules in estrogen target tissue. Science 200, 312–314.PubMedCrossRefGoogle Scholar
  65. 65.
    Okey, A. B. and Truant, G. S. (1975) Cannabis-demasculinizes rats but is not estrogenic. Life Sci. 17, 1113–1118.PubMedCrossRefGoogle Scholar
  66. 66.
    Pace, H. B., Davis, W. M., and Borgen, L. A. (1971) Teratogenesis and marihuana. Ann. NYAcad. Sci. 191, 123–131.CrossRefGoogle Scholar
  67. 67.
    Persaud, T. V. N. and Ellington, A. C. (1967) Cannabis in early pregnancy. Lancet 2, 1306.PubMedCrossRefGoogle Scholar
  68. 68.
    Persaud, T. V. N. and Ellington, A. C. (1968) Teratogenic activity of cannabis resin. Lancet 2, 406–407.PubMedCrossRefGoogle Scholar
  69. 69.
    Phillips, R. N., Turk, R. F., and Forney, R. B. (1971) Acute toxicity of A9-tetrahydrocannabinol in rats and mice. Proc. Soc. Exp. Biol. Med. 136, 260–263.PubMedGoogle Scholar
  70. 70.
    Prigge, E. and Hochrainer, D. (1977) Effects of carbon monoxide inhalation on erythropoiesis and cardiac hypertrophy in fetal rats. Toxicol. Appl. Pharmacol. 42, 225–228.PubMedCrossRefGoogle Scholar
  71. 71.
    Reckzeh, G., Donten Will, W., and Leuschner, F. (1975) Testing of cigarette smoke inhalation for teratogenicity in rats. Toxicology 4, 289–295.PubMedCrossRefGoogle Scholar
  72. 72.
    Rosenfeld, J. J., Bowins, B., Roberts, J., Perkins, J., and Macpherson, A. S. (1974) Mass fragmentographic assay for A9-tetrahydrocannabinol in plasma. Anal. Chem. 46, 2232–2234.PubMedCrossRefGoogle Scholar
  73. 73.
    Rosenkrantz, H. (1976) The immune response and marihuana, in Marihuana: Chemistry, Biochemistry and Cellular Effects. ( Nahas, G. G., ed.) Springer-Verlag, New York, pp. 441–456.Google Scholar
  74. 74.
    Rosenkrantz, H. and Braude, M. C. (1974) Acute, subacute and 23-day chronic marihuana inhalation toxicities in the rat. Toxicol. Appl. Pharmacol. 28, 428–441.PubMedCrossRefGoogle Scholar
  75. 75.
    Rosenkrantz, H. and Braude, M. C. (1975) Rat inhalation toxicity of Turkish marihuana. Pharmacologist 17, 181.Google Scholar
  76. 76.
    Rosenkrantz, H. and Braude, M. C. Comparative chronic toxicities of A9-tetrahydrocannabinol administered by inhalation or orally in rat, in The Pharmacology of Marihuana. (Braude, M. C. and Szara, S. eds.) Raven, New York, pp. 571–584, 1976Google Scholar
  77. 77.
    Rosenkrantz, H., Fleischman, R. W., and Baker, J. R. (1978) Embryotoxicity of marihuana by inhalation. Fed. Proc. 37, 737.Google Scholar
  78. 78.
    Rosenkrantz, H., Hayden, D. W., and Braude, M. C. (1976) Inhalation toxicity of Turkish marihuana, cannabichromene and cannabidiol. Fed. Proc. 35, 643.Google Scholar
  79. 79.
    Rosenkrantz, H., Heyman, I. A., and Braude, M. C. (1974) Inhalation, parenteral and oral LD 50 values of A9tetrahydrocannabinol in Fischer rats. Toxicol. Appl. Pharmacol. 28, 18–27.PubMedCrossRefGoogle Scholar
  80. 80.
    Rosenkrantz, H., Thompson, G. R., and Braude, M. C. (1972) Oral and parenteral formulations of marihuana constituents. J. Pharm. Sci. 61, 1106–1112.PubMedCrossRefGoogle Scholar
  81. 81.
    Ryrfeldt, A., Ramsay, C. H., Nilsson, I. M., Widman, M., and Agurell, S. (1973) Whole-body autoradiography of Al-tetrahydrocannabinol in the rat. Psychopharmacol. 27, 141–156.Google Scholar
  82. 82.
    Sassenrath, E. N. and Chapman, L. E (1975) Tetrahydrocannabinol-induced manifestations of the “marihuana syndrome” in group-living macaques. Fed. Proc. 34, 1666–1670.PubMedGoogle Scholar
  83. 83.
    Schou, J., Prockop, L. D., Dahlstrom, G., and Rohde, C. (1977) Penetration of delta-9-tetrahydrocannabinol and 11-hydroxy-delta-9-tetrahydrocannabinol through the blood-brain barrier. Acta Pharmacol. Toxicol. 41, 33–38.CrossRefGoogle Scholar
  84. 84.
    Shannon, M. E. and Fried, P. A. (1972) The macro-and microdistribution and polymorphic electroencephalographic effects of A9-tetrahydrocannabinol in the rat. Psychopharmacol. 27, 141–156.CrossRefGoogle Scholar
  85. 85.
    Singer, P. R., Seibetta, J. J., and Rosen, M. G. (1973) Simulated marihuana smoke in the maternal and fetal guinea pig. Am. J. Obs. Gyn. 117, 331–340.Google Scholar
  86. 86.
    Skinner, R. R (1972) Determination of submicrogram amounts of A9-THC (tetrahydrocannabinol) and its metabolites. Proc. West. Pharmacol. Soc. 15, 136–138.Google Scholar
  87. 87.
    Smith, C. G., Besch, N. F., Smith, R. G., and Besch, P. K. (1978) Mechanism for the anti-gonadotrophic action of tetrahydrocannabinol (THC). Fed. Proc. 37, 724.Google Scholar
  88. 88.
    Smith, C. G. and Moore, C. E. (1976) Effect of delta-9-tetrahydrocannabinol (THC) on the secretion of male sex hormone in the rhesus monkey. The Pharmacologist 18, 248.Google Scholar
  89. 89.
    Symons, A. M., Teale, J. D., and Marks, V. (1976) Effect of A9-tetrahydrocannabinol on the hypothalamicpituitary-gonadal system in the maturing male. J. Endocrin. 68, 43P - 44 P.CrossRefGoogle Scholar
  90. 90.
    Teale, J. D., Forman, E. J., King, L. J., and Marks, V. (1974) Radioimmunoassay of cannabinoids in blood and urine. Lancet 2, 533–555.Google Scholar
  91. 91.
    Thomas, R. J. (1975) Toxicologic and teratologic effects of A9-tetrahydrocannabinol in the zebrafish embryo. Toxicol. Appl. Pharmacol. 32, 184–190.PubMedCrossRefGoogle Scholar
  92. 92.
    Uyeno, E. T. (1973) A9-Tetrahydrocannabinol administration during pregnancy of the rat. Proc. West. Pharmacol. Soc. 16, 64–67.Google Scholar
  93. 93.
    Uyeno, E. T. (1975) A9-Tetrahydrocannabinol administered to pregnant rats. Pharmacologist 17, 181.Google Scholar
  94. 94.
    Vardaris, R. M., Weisz, D. J., Fazel, A., and Rawitch, A. B. (1976) Chronic administration of delta-9-tetrahydrocannabinol to pregnant rats: studies of pup behavior and placental transfer. Pharmacol. Biochern. Behay. 4, 249–254.CrossRefGoogle Scholar
  95. 95.
    Venable, J. W. (1939) Intrauterine bleeding in the pregnant albino rat. The “ placental sign ”. Anat. Rec. 74, 273–293.CrossRefGoogle Scholar
  96. 96.
    Warner, W. and Harris, L. S. (1978) Inhibition of corticosteroidogenesis by delta-9-tetrahydrocannabinol. Endocrinology 101, 1815–1820.CrossRefGoogle Scholar
  97. 97.
    Willinsky, M. D., Kalant, H., Meresz, O., Endrenyi L., and Woo, N. (1974) Distribution and metabolism in vivo of carbon 14-labeled tetrahydrocannabinol in the rat. Eur. J. Pharmacol. 27, 106–119.PubMedCrossRefGoogle Scholar
  98. 98.
    Wilson, J. C. and Warkry, J. (1964) Methods of administering agents and detecting malformations in experimental animals, in Teratology, Principles and Techniques,University of Chicago Press, Chicago, IL, pp. X-X.Google Scholar
  99. 99.
    Wright, P. L., Smith, S. H., Keplinger, M. L., Calandra, J. C., and Braude, M. C. (1976) Reproductive and teratologic studies with A9-tetrahydrocannabinol and crude marihuana extract. Toxicol. Appl. Pharmacol. 38, 223–235.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Harris Rosenkrantz

There are no affiliations available

Personalised recommendations